Adalimumab Treatment in Biologically Naïve Crohn's Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement

Background. Adalimumab (ADA) is effective for patients with Crohn's disease (CD). However, there have been few reports on ADA therapy with respect to its relationship with pathologic findings and drug efficacy in biologically naïve CD cases. Methods. Fifteen patients with active biologically na...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mizoshita, Tsutomu, Tanida, Satoshi, Tsukamoto, Hironobu, Ozeki, Keiji, Katano, Takahito, Nishiwaki, Hirotaka, Ebi, Masahide, Mori, Yoshinori, Kubota, Eiji, Kataoka, Hiromi, Kamiya, Takeshi, Joh, Takashi
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2014
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4009194/
https://ncbi.nlm.nih.gov/pubmed/24829572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/687257
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados